Table 3 Comparative analysis of outcomes of patient groups according to recurrence status.

From: Prediction of recurrence using hematologic and urinary markers in intravesical Bacillus calmette Guerin treated bladder cancer

 

Recurrence negative (n:65)

Recurrence positive(n:12)

P*

Neutrophil /T Cell_1B

236.08 ± 375.31

321.81 ± 306.37

0.048

Neutrophil /T Cell_1A

128.03 ± 143.02

198.68 ± 197.29

0.08

Neutrophil /T Cell_6B

63.35 ± 153.58

107.64 ± 85.54

0.005

Neutrophil /T Cells_6A

54.14 ± 71.832

69.452 ± 53.430

0.023

LMR

4.725 ± 1.607

4.125 ± 1.623

0.095

NLR

2.527 ± 1.009

2.798 ± 0.99

0.247

  1. 1B: Pre-1st BCG urine sample analysis 1 A: Post-1st BCG urine sample analysis 6B: Pre-6th BCG urine sample analysis 6 A: Post-6st BCG urine sample analysis LMR: Lymphocyte to Monocyte Ratio NLR: Neutrophil-to-Lymphocyte Ratio *Mann-Whitney U test.
Back to article page